These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 6343376

  • 1. Studies of C1 inactivator-plasma kallikrein complexes in purified systems and in plasma.
    Lewin MF, Kaplan AP, Harpel PC.
    J Biol Chem; 1983 May 25; 258(10):6415-21. PubMed ID: 6343376
    [Abstract] [Full Text] [Related]

  • 2. Assessment of Hageman factor activation in human plasma: quantification of activated Hageman factor-C1 inactivator complexes by an enzyme-linked differential antibody immunosorbent assay.
    Kaplan AP, Gruber B, Harpel PC.
    Blood; 1985 Sep 25; 66(3):636-41. PubMed ID: 3875374
    [Abstract] [Full Text] [Related]

  • 3. Distribution of plasma kallikrein between C-1 inactivator and alpha 2-macroglobulin in plasma utilizing a new assay for alpha 2-macroglobulin-kallikrein complexes.
    Harpel PC, Lewin MF, Kaplan AP.
    J Biol Chem; 1985 Apr 10; 260(7):4257-63. PubMed ID: 2579948
    [Abstract] [Full Text] [Related]

  • 4. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II.
    Joseph K, Tholanikunnel BG, Bygum A, Ghebrehiwet B, Kaplan AP.
    J Allergy Clin Immunol; 2013 Aug 10; 132(2):470-5. PubMed ID: 23672780
    [Abstract] [Full Text] [Related]

  • 5. Human plasma alpha 2-macroglobulin. An inhibitor of plasma kallikrein.
    Harpel PC.
    J Exp Med; 1970 Aug 01; 132(2):329-52. PubMed ID: 4101346
    [Abstract] [Full Text] [Related]

  • 6. Detection of activation of the contact system of coagulation in vitro and in vivo: quantitation of activated Hageman factor-C-1-inhibitor and kallikrein-C-1-inhibitor complexes by specific radioimmunoassays.
    Nuijens JH, Huijbregts CC, Cohen M, Navis GO, de Vries A, Eerenberg AJ, Bakker JC, Hack CE.
    Thromb Haemost; 1987 Aug 04; 58(2):778-85. PubMed ID: 2445044
    [Abstract] [Full Text] [Related]

  • 7. Plasma kallikrein activation and inhibition during typhoid fever.
    Colman RW, Edelman R, Scott CF, Gilman RH.
    J Clin Invest; 1978 Feb 04; 61(2):287-96. PubMed ID: 74379
    [Abstract] [Full Text] [Related]

  • 8. Plasma total prekallikrein/kallikrein activity in rheumatoid arthritis with and without amyloidosis. Increased kaolin-stimulated activity in patients with amyloidosis.
    Teppo AM, Pakkanen R, Maury CP.
    Acta Med Scand; 1985 Feb 04; 217(4):397-402. PubMed ID: 2409750
    [Abstract] [Full Text] [Related]

  • 9. C1-inhibitor polymers activate the FXII-dependent kallikrein-kinin system: Implication for a role in hereditary angioedema.
    Madsen DE, Sidelmann JJ, Biltoft D, Gram J, Hansen S.
    Biochim Biophys Acta; 2015 Jun 04; 1850(6):1336-42. PubMed ID: 25800206
    [Abstract] [Full Text] [Related]

  • 10. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
    España F, Ratnoff OD.
    J Lab Clin Med; 1983 Oct 04; 102(4):487-99. PubMed ID: 6604770
    [Abstract] [Full Text] [Related]

  • 11. Determination of prekallikrein in human plasma: optimal conditions for activating prekallikrein.
    Kluft C.
    J Lab Clin Med; 1978 Jan 04; 91(1):83-95. PubMed ID: 618993
    [Abstract] [Full Text] [Related]

  • 12. Cold promoted activation and factor XII, prekallikrein and C1-inhibitor.
    Czendlik C, Lämmle B, Duckert F.
    Thromb Haemost; 1985 Apr 22; 53(2):242-4. PubMed ID: 2410997
    [Abstract] [Full Text] [Related]

  • 13. Complexes between C1-inhibitor, kallikrein, high molecular weight kininogen, plasma thromboplastin antecedent, and plasmin in normal human plasma and hereditary angioneurotic edema plasmas containing dysmorphic C1-inhibitors: role of cold activation.
    Donaldson VH, Harrison RA.
    Blood; 1982 Jul 22; 60(1):121-9. PubMed ID: 6211203
    [No Abstract] [Full Text] [Related]

  • 14. Western blot analyses of prekallikrein and its activation products in human plasma.
    Veloso D, Colman RW.
    Thromb Haemost; 1991 Apr 08; 65(4):382-8. PubMed ID: 1711719
    [Abstract] [Full Text] [Related]

  • 15. Alteration of factor VII activity by activated Fletcher factor (a plasma kallikrein): a potential link between the intrinsic and extrinsic blood-clotting systems.
    Saito H, Ratnoff OD.
    J Lab Clin Med; 1975 Mar 08; 85(3):405-15. PubMed ID: 234996
    [Abstract] [Full Text] [Related]

  • 16. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.
    Scott CF, Silver LD, Schapira M, Colman RW.
    J Clin Invest; 1984 Apr 08; 73(4):954-62. PubMed ID: 6561202
    [Abstract] [Full Text] [Related]

  • 17. Pathways of kinin formation and role in allergic diseases.
    Kaplan AP, Silverberg M, Ghebrehiwet B, Atkins P, Zweiman B.
    Clin Immunol Immunopathol; 1989 Jan 08; 50(1 Pt 2):S41-51. PubMed ID: 2910589
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of plasma kallikrein by C1-inhibitor: role of endothelial cells and the amino-terminal domain of C1-inhibitor.
    Ravindran S, Grys TE, Welch RA, Schapira M, Patston PA.
    Thromb Haemost; 2004 Dec 08; 92(6):1277-83. PubMed ID: 15583734
    [Abstract] [Full Text] [Related]

  • 19. Inactivation of kallikrein in human plasma.
    van der Graaf F, Koedam JA, Bouma BN.
    J Clin Invest; 1983 Jan 08; 71(1):149-58. PubMed ID: 6184384
    [Abstract] [Full Text] [Related]

  • 20. Prekallikrein activation and kallikrein inactivation in human plasma.
    van der Graaf F, Keus JF, Koedam JA, Rietveld A, Bouma BN.
    Adv Exp Med Biol; 1983 Jan 08; 156():143-8. PubMed ID: 6190365
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.